Publication | Closed Access

Budget Impact Modeling for a Single-Tablet Formulation of Ibuprofen and Famotidine for Prevention of Upper Gastrointestinal Ulcers in Patients With Osteoarthritis and/or Rheumatoid Arthritis

Drug SafetyRheumatologyAnti-inflammatoryPharmacologyOsteoarthritisSingle-tablet FormulationBudget Impact ModelingPharmacoeconomicsPharmacotherapyMedicinePharmacological IssueRheumatoid ArthritisPharmacoepidemiology